Paper455263
5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
MacDonald JS and 5 others. Cancer, 1979. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Papers, record 455263. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/455263
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Doxorubicin | Major topic |
| Fluorouracil | Major topic |
| Mitomycins | Major topic |
| Stomach Neoplasms | Major topic |
| Aged | |
| Bone Marrow | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Remission, Spontaneous | |
| Time Factors |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 19343158 | Evolution of preoperative and postoperative therapies in the management of localized gastroesophageal cancers. | Gastrointest Cancer Res | 2007 | https://conductscience.org/library/papers/19343158 | PubMed |
| 17353926 | Oxaliplatin, 5-fluorouracil/leucovorin and epirubicin as first-line treatment in advanced gastric carcinoma: a phase II study. | Br J Cancer | 2007 | https://conductscience.org/library/papers/17353926 | PubMed |
| 14676810 | Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C. | Br J Cancer | 2003 | https://conductscience.org/library/papers/14676810 | PubMed |
| 9725015 | Derivatization of 5-fluorouracil with 4-bromomethyl-7-methoxycoumarin for determination by liquid chromatography-mass spectrometry. | J Am Soc Mass Spectrom | 1998 | https://conductscience.org/library/papers/9725015 | PubMed |
| 9654592 | Chemotherapy of oesophago-gastric cancer. | Pathol Oncol Res | 1998 | https://conductscience.org/library/papers/9654592 | PubMed |
| 7846911 | Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. | World J Surg | 1994 | https://conductscience.org/library/papers/7846911 | PubMed |
| 7687933 | Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/7687933 | PubMed |
| 7676702 | Review of adjuvant chemotherapy for gastric cancer. | World J Surg | 1995 | https://conductscience.org/library/papers/7676702 | PubMed |
| 7248155 | Transition from laboratory to clinic in cancer treatment. Abstracts of symposium papers. | Br J Cancer | 1981 | https://conductscience.org/library/papers/7248155 | PubMed |
| 6925983 | A follow-up study on chemoimmunotherapy (5-fluorouracil and BCG) in advanced gastric cancer. | Cancer Immunol Immunother | 1982 | https://conductscience.org/library/papers/6925983 | PubMed |
| 6897785 | [Chemotherapy of gastric carcinoma]. | Langenbecks Arch Chir | 1982 | https://conductscience.org/library/papers/6897785 | PubMed |
| 6897021 | Treatment of advanced gastric carcinoma with 5-fluorouracil adriamycin, and mitomycin C (FAM). | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6897021 | PubMed |
| 6793759 | Late results of postoperative long term cancer chemotherapy for advanced carcinoma of the stomach. | Jpn J Surg | 1981 | https://conductscience.org/library/papers/6793759 | PubMed |
| 6668775 | Combination chemotherapy enhances survival of patients with unresectable gastric cancer. | Jpn J Surg | 1983 | https://conductscience.org/library/papers/6668775 | PubMed |
| 6406513 | Chemotherapeutic study on Yoshida sarcoma ascites cells implanted into the glandular stomach of rats. Monotherapy with 5-fluorouracil, methyl-CCNU, mitomycin C, adriamycin, and cytosine arabinoside, and combination therapy with respective two-drug combinations. | J Cancer Res Clin Oncol | 1983 | https://conductscience.org/library/papers/6406513 | PubMed |
| 3154829 | Clonogenic assay of gastric adenocarcinoma stem cells--clonogenic assay, stomach cancer. | Korean J Intern Med | 1987 | https://conductscience.org/library/papers/3154829 | PubMed |
| 3066394 | Gastric cancer--the recognition of a chemosensitive tumour. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3066394 | PubMed |
| 2514857 | Cytotoxic drugs for gastric and colorectal cancer. | BMJ | 1989 | https://conductscience.org/library/papers/2514857 | PubMed |
| 1911206 | A less toxic regimen of 5-fluorouracil and high-dose folinic acid for advanced gastrointestinal adenocarcinomas. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1911206 | PubMed |
| 1905707 | A cooperative randomized study on tegafur plus mitomycin C versus combined tegafur and uracil plus mitomycin C in the treatment of advanced gastric cancer. | Jpn J Cancer Res | 1991 | https://conductscience.org/library/papers/1905707 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/455263
GET https://conductscience.org/api/papers/v1/455263/cited_by?page=2